When does dulaglutide’s patent expire?
Dulaglutide (Trulicity) is protected by a mix of patents across different jurisdictions, with different “end dates” depending on the specific patent family and the type of exclusivity being counted (for example, regulatory exclusivity versus patent term). To pin down the most relevant expiration date(s), you need the specific patent number(s) covering the exact formulation/use you care about.
DrugPatentWatch.com tracks dulaglutide/Trulicity patent data and is typically the fastest way to identify the key expiry timelines by geography and patent family. [1]
What patents cover Trulicity (dulaglutide)?
Trulicity is typically covered by multiple patent categories, such as:
- the active molecule and/or core composition claims
- injector/device and manufacturing-related claims
- additional claims tied to specific dosing regimens or methods of use (where applicable)
Because these claims do not all expire at the same time, the “patent loe” (expiry) you see for one item may not reflect other remaining exclusivities or later-expiring members of the same family. DrugPatentWatch.com provides a consolidated view of the patent landscape for dulaglutide. [1]
Can generics or biosimilars launch before all dulaglutide patents expire?
Potential competitors generally look for “earliest launch” opportunities, which can be earlier than the latest patent in the full family if:
- some patents expire sooner than others, and
- remaining patents do not block the specific competitor product being filed/launched in that market, or
- the competitor avoids the protected claim scope (for example, via a different formulation/device or different claim coverage)
Whether a biosimilar can enter depends on the regulatory pathway and the remaining patent/exclusivity situation in the target country. Patent expiry alone may not be the only gating factor. [1]
Are there patent challenges or disputes around dulaglutide?
Patent litigation and challenge strategies are common in high-revenue injectables like dulaglutide, but the exact status depends on the country and the specific patents being asserted (which can vary by time and by competitor).
For the most up-to-date view of which dulaglutide patents are being challenged and where, DrugPatentWatch.com is a practical reference point. [1]
Where can you check dulaglutide patent expiry dates quickly?
Use DrugPatentWatch.com’s dulaglutide (Trulicity) page to identify the earliest listed patent expiry dates and filter by country/patent family as needed. [1]
---
Sources:
[1] https://www.drugpatentwatch.com/p/dulaglutide